Senior insider sale
Chief Medical Officer at ARS PHARMACEUTICALS, INC. — senior position signals high conviction
$988.4K
162.69K shares
What this filing means
TANIMOTO SARINA plans to sell 162.69K shares of ARS PHARMACEUTICALS, INC. valued at approximately $988.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/31/2026ACC: 0001950047-26-008852
Officer10% Owner· Chief Medical Officer
Since Nov 2022
162.69K
Shares to sell
$988.4K
Approx. market value
63.29K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
8/31/2026
63.29KTotal acquired63.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/31/2026 | Stock Option Exercise Cash | 63.29K | — |
| Total | 63.29K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
25K
Market value
$148.0K
8/20/2026
—Completed
Units to sell
25K
Market value
$161.2K
8/19/2026
—Completed
Units to sell
49.40K
Market value
$311.2K
8/18/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
63.29K
Market value
$368.1K
8/31/2026
Total
Units
162.69K
Value
$988.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/20/2026 | 25K | $148.0K | — | Completed |
8/19/2026 | 25K | $161.2K | — | Completed |
8/18/2026 | 49.40K | $311.2K | — | Completed |
| Planned — Approximate Date | ||||
8/31/2026 | 63.29K | $368.1K | NASDAQ | Planned |
| Total | 162.69K | $988.4K | ||